GHK-Cu (copper tripeptide-1) is a cosmetic ingredient and is not approved by the FDA, EMA, or any comparable regulator for the treatment, cure, or prevention of androgenetic alopecia, telogen effluvium, or any other hair-loss condition
however, studies have shown that exendin-4, a GLP-1R agonist, promotes reexpression of RGS16 in cells to promote proliferation (48)
Intermittent claudication can lead to pain when walking or running, because damage or narrowing of an artery leads to poor blood supply
The safety data available derive from Phase 2 clinical trials (Jastreboff et al., NEJM, 2023), which, whilst informative, represent a relatively limited population and duration of follow-up compared to post-marketing surveillance
Algunos pacientes logran sus objetivos con dosis intermedias, sin necesidad de llegar a la dosis mxima